Table 2. PEDro scale of the included studies; * = was not counted for the final score; 1 = one point awarded; 0 = no point awarded. |
|
Inclusion criteria |
Random allocation |
Concealed allocation |
Similarity at baseline |
Subject blinding |
Therapist blinding |
Assessor blinding |
>85% follow-up |
Intention to treat analysis |
Between-group comparison |
Point estimates and variability |
Total |
Smith et al., 2018 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Lin et al., 2020 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Fairall et al., 2017 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Richman et al., 2019 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Škarabot et al., 2015 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
7 |
Hodgson et al., 2019 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
7 |
Kyranoudis et al., 2019 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Che Hsiu et al., 2021 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Somers et al., 2020 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
9 |
Smith et al., 2019 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
9 |
Peacock et al., 2014 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Cunha et al., 2021 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
9 |
|
|